People Aren't Buying Highs; They Are Buying Dips
U.S. equities slide for a fourth consecutive session on mixed earnings although stocks pared losses to end the day nearly unchanged. One of the top stories today was President Trump meeting with various heads of top Pharma companies (LLY , MRK, etc.), and the group has seen a bounce (biotech as well) following commentary he will soon announce a new FDA leader whose mission, in part, will be to speed the drug approval process (helping names like PFE and LLY which missed earnings earlier turn higher and lift biotech by 2%). All eyes on AAPL after the close posting record revenue and an all-time record in $246 billion cash. Key events this week will include the FOMC meeting (starts today with results tomorrow – as expectations are for rates to remain on hold while waiting for more clarity on fiscal policy) and the monthly jobs data released on Friday.
Video length: 00:06:31
Disclaimer: Neither TheoTrade or any of its officers, directors, employees, other personnel, representatives, agents or independent contractors is, in such capacities, a licensed financial adviser, ...
more
As they should. #Exxon may be a great dip buy given they absorbed their asset write off in 1 quarter. Especially since they are liable to add it back in later which is why the whole baloney about their assets not being written off is so bunkus. In reality, if they followed the suit guidance they should write up their assets as well to market because most of their assets are undervalued when they bought them as they should be. This is why they are the leaders in oil.
If we see decent revenues increase this year the stock will surge. $XOM